Overview

A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine both the magnitude and duration of viral load (copies/mL) reduction after a single dose of OPN-019. The variability associated with viral counts will be utilized to inform the study design of future studies.
Phase:
Phase 1
Details
Lead Sponsor:
Optinose US Inc.